Use the following links to access the PubMed references for the studies referenced within this site.
Aşik I, Göktuğ A, Gülay I, Alkiş N, Uysalel A. Comparison of bupivacaine 0.2% and ropivacaine 0.2% combined with fentanyl for epidural analgesia during labour. Eur J Anaesthesiol. 2002;19:263-270.
http://www.ncbi.nlm.nih.gov/pubmed/12074415
Writer WDR, Stienstra R, Eddleston JM, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998;81:713-717.
http://www.ncbi.nlm.nih.gov/pubmed/10193281
Writer WDR, Stienstra R, Eddleston JM, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998;81:713-717.
http://www.ncbi.nlm.nih.gov/pubmed/10193281
NAROPIN® Prescribing Information. Data on file.
Download PDF
Aşik I, Göktuğ A, Gülay I, Alkiş N, Uysalel A. Comparison of bupivacaine 0.2% and ropivacaine 0.2% combined with fentanyl for epidural analgesia during labour. Eur J Anaesthesiol. 2002;19:263-270.
http://www.ncbi.nlm.nih.gov/pubmed/12074415
Writer WDR, Stienstra R, Eddleston JM, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998;81:713-717.
http://www.ncbi.nlm.nih.gov/pubmed/10193281
NAROPIN Prescribing Information. Data on file.
Download PDF
Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth. 1994;72:164-169.
http://www.ncbi.nlm.nih.gov/pubmed/8110567
McGlade DP, Kalpokas MV, Mooney PH, et al. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.
http://www.ncbi.nlm.nih.gov/pubmed/9807606
Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology. 1995;82:1346-1352.
http://www.ncbi.nlm.nih.gov/pubmed/7793647
Griffin RP, Reynolds F. Extradural anaesthesia for caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth. 1995;74:512-516.
http://www.ncbi.nlm.nih.gov/pubmed/7772423
Crosby E, Sandler A, Finucane B, et al. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarian section. Can J Anaesth. 1998;45:1066-1071.
http://www.ncbi.nlm.nih.gov/pubmed/10021954
McGlade DP, Kalpokas MV, Mooney PH, et al. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.
http://www.ncbi.nlm.nih.gov/pubmed/9807606
Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth. 1994;72:164-169.
http://www.ncbi.nlm.nih.gov/pubmed/8110567
Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivicaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774.
http://www.ncbi.nlm.nih.gov/pubmed/16931694
Hickey R, Hoffman J, Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anesthesiology. 1991;74:639-642.
http://www.ncbi.nlm.nih.gov/pubmed/2008942
NAROPIN Prescribing Information. Data on file.
Download PDF
Bertini L, Tageriello V, Mancini S, et al. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med. 1999;24:514-518.
http://www.ncbi.nlm.nih.gov/pubmed/10588554
Chelly JE, Casati A, Al-Samsam T, Coupe K, Criswell A, Tucker J. Continuous lumbar plexus block for acute postoperative pain management after open reduction and internal fixation of acetabular fractures. J Orthop Trauma. 2003;17:362-367.
http://www.ncbi.nlm.nih.gov/pubmed/12759641
Bertini L, Tageriello V, Mancini S, et al. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med. 1999;24:514-518.
http://www.ncbi.nlm.nih.gov/pubmed/10588554
Rawal N, Allvin R, Axelsson K, et al. Patient-controlled regional analgesia (PCRA) at home: Controlled comparison between bupivacaine and ropivacaine brachial plexus analgesia. Anesthesiology. 2002;96:
1290-1296.
http://www.ncbi.nlm.nih.gov/pubmed/12170038
Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology. 1995;82:1346-1352.
http://www.ncbi.nlm.nih.gov/pubmed/7793647
Griffin RP, Reynolds F. Extradural anaesthesia for caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth. 1995;74:512-516.
http://www.ncbi.nlm.nih.gov/pubmed/7772423
Crosby E, Sandler A, Finucane B, et al. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarian section. Can J Anaesth. 1998;45:1066-1071.
http://www.ncbi.nlm.nih.gov/pubmed/10021954
Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.
http://www.ncbi.nlm.nih.gov/pubmed/2679230
Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.
http://www.ncbi.nlm.nih.gov/pubmed/9175963
Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.
http://www.ncbi.nlm.nih.gov/pubmed/2679230
Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.
http://www.ncbi.nlm.nih.gov/pubmed/9175963
Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.
http://www.ncbi.nlm.nih.gov/pubmed/2679230
Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.
http://www.ncbi.nlm.nih.gov/pubmed/9175963
Lee A, Fagan D, Lamont M, Tucker GT, Halldin M, Scott DB. Disposition kinetics of ropivacaine in humans. Anesth Analg. 1989;69:736-738.
http://www.ncbi.nlm.nih.gov/pubmed/2589653
Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 1979;51:285-287.
http://www.ncbi.nlm.nih.gov/pubmed/484889
NAROPIN Prescribing Information. Data on file.
Download PDF
Sensorcaine [package insert]. Schaumburg, IL: APP Pharmaceuticals, LLC; 2009.
http://www.drugs.com/pro/sensorcaine.html
Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivicaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774.
http://www.ncbi.nlm.nih.gov/pubmed/16931694
Bertini L, Tageriello V, Mancini S, et al. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: A clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med. 1999;24:514-518.
http://www.ncbi.nlm.nih.gov/pubmed/10588554
Hansen TG. Ropivacaine: a pharmacological review. Expert Rev Neurother. 2004;4:781-791.
http://www.ncbi.nlm.nih.gov/pubmed/15853505
Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.
http://www.ncbi.nlm.nih.gov/pubmed/9175963
McGlade DP, Kalpokas MV, Mooney PH, Chamley D, Mark AH, Torda TA. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.
http://www.ncbi.nlm.nih.gov/pubmed/9807606
Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.
http://www.ncbi.nlm.nih.gov/pubmed/2679230
Zaric D, Nydahl P-A, Phillipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: a double-blind study. Reg Anesth. 1996;21:14-25.
http://www.ncbi.nlm.nih.gov/pubmed/8826020
NAROPIN is indicated for the production of local or regional anesthesia for surgery and for acute pain management.
